Copyright
©The Author(s) 2018.
World J Gastroenterol. Aug 28, 2018; 24(32): 3626-3636
Published online Aug 28, 2018. doi: 10.3748/wjg.v24.i32.3626
Published online Aug 28, 2018. doi: 10.3748/wjg.v24.i32.3626
Ref. | Criteria | Survival, time and rate (%) | Recurrence, time and rate (%) |
Schwartz et al[68], 2008 | FAI < 0.27 | 5 yr (10) | |
Dvorchick et al[69], 2008 | FAI and macrovascular invasion (Pittsburg criteria) | Stage I (FAI ≤ 20% and no macrovascular invasion) - 5 yr DFS (92.8) | |
Miltiadous et al[67], 2015 | Progenitor cell markers (CK19 or S2 signature) | 5 yr (67) | 5 yr (19) |
Sugimachi et al[70], 2015 | miR-718 and his target gene HOXB8 | 5 yr (≈ 80) | |
Barry et al[71], 2012 | 67 miRNA | ||
Liese et al[72], 2016 | miR-214, miR-3187 and MC | 5 yr DFS (≈ 90) |
- Citation: Pavel MC, Fuster J. Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions. World J Gastroenterol 2018; 24(32): 3626-3636
- URL: https://www.wjgnet.com/1007-9327/full/v24/i32/3626.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i32.3626